Tag

drug-2

BioInvent announces a fourth complete response in Phase 1/2 trial

April 26, 2023

BioInvent International has announced that …

Carlos de Sousa

Ultimovacs adjusts guidance on timeline for INITIUM readout

April 26, 2023

Ultimovacs has adjusted guidance from …

SynAct Pharma completes patient recruitment for Phase 2b study

April 26, 2023

SynAct Pharma has completed patient …

First healthy volunteer dosed in the Herantis’ Phase 1a trial

April 19, 2023

Herantis Pharma has announced the …

Michael Engsig and Agnete Fredriksen

Nykode announces positive final results from its Phase 2 trial

April 19, 2023

Nykode Therapeutics has announced results …

Preclinical data validate Evaxion’s AI-based platform

April 19, 2023

Evaxion Biotech has announced preclinical …

Nikolai Brun

Affibody presents long-term results with izokibep

April 19, 2023

Affibody have shared long-term 46-week …

pipette

EXACT Therapeutics presents encouraging data

March 30, 2023

The company has presented data …

Nikolai Brun

Affibody presents topline 12-week data

March 20, 2023

Affibody has announced that data …

First patient dosed in Targovax study

March 17, 2023

Targovax has announced that the …

First patient dosed in BerGenBio Phase 1b/2a trial

March 14, 2023

The company has announced that …

Renee-Aguiar-Lucander

Calliditas announces positive topline results

March 13, 2023

Calliditas Therapeutics has announced results …

Magnus Corfitzen

Ascelia Pharma achieves major milestone

February 27, 2023

The company has announced the …

Göran Forsberg Photo Håkan Sandbring

Cantargia advances its TRIFOUR trial

February 27, 2023

The company has reported favorable …

Modus Therapeutics announces positive Phase 1b data

February 22, 2023

Modus Therapeutics has announced positive …

Martin Olin

BerGenBio announces positive Phase 2 data

February 21, 2023

The company has announced topline …

1
2